ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,738.52
-1.78%
US Tech 100
19,646.40
0.61%
다우존스 지수
42,579.08
-0.99%
Bitcoin
89,078.01
-0.95%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE

  6. Eli Lilly and Co (LLY) 시세

Eli Lilly and Co

Eli Lilly and Co (LLY)

Eli Lilly and Company
Lilly Eli and Co
912.76
-16.96
(-1.82%)
마감 07 3월 6:00AM
15분 지연
912.76
0.00
( 0.00% )
시간외 단일가: 6:30PM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
912.76
매수가
-
매도가
-
거래량
205
0.00 일간 변동폭 0.00
711.4001 52주 범위 972.53
market_cap
865.452B
전일 종가
912.76
개장가
-
최근 거래 시간
1
@
909.52
마지막 거래 시간
18:23:13
재정 규모
-
VWAP
-
평균 볼륨(3m)
3,636,576
발행 주식
948,169,999
배당수익률
0.66%
주가수익률
81.72
주당순이익(EPS)
11.17
매출
45.04B
순이익
10.59B

Eli Lilly and Co 정보

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.lilly.com
본부
Indianapolis, Indiana, USA
설립됨
-
Eli Lilly and Co is listed in the Pharmaceutical Preparations sector of the 뉴욕 증권거래소 with ticker LLY. The last closing price for Eli Lilly was US$912.76. Over the last year, Eli Lilly shares have traded in a share price range of US$ 711.4001 to US$ 972.53.

Eli Lilly currently has 948,169,999 shares in issue. The market capitalisation of Eli Lilly is US$865.45 billion. Eli Lilly has a price to earnings ratio (PE ratio) of 81.72.

Eli Lilly (LLY) 옵션 플로우 요약

전체 옵션 플로우 보기

전체 흐름

강세

순 프리미엄

53M

Calls / Puts

413.10%

매수 / 매도

111.11%

OTM / ITM

49.40%

Sweeps 비율

1.34%

LLY 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
05 3월 2025
LLY (-1.82%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 3월 2025
LLY (-1.82%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 3월 2025
LLY (-1.82%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
04 3월 2025
LLY (-1.82%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 2월 2025
LLY (-1.82%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 2월 2025
LLY (-1.82%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
26 2월 2025
LLY (-1.82%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
110.921.21085780183901.84935.625892.61293553569920.99715679CS
437.774.31662076138874.99935.625841.493375043889.67856624CS
12132.7617.0205128205780935.625725.013636576817.61289049CS
261.40.153616573034911.36942.35711.40013593810828.41473983CS
52140.92518.2584360647771.835972.53711.40013263589830.01313411CS
156652.05250.105481186260.71972.53257.863103073568.96488147CS
260778.77581.215016046133.99972.53116.553274063404.45893254CS

LLY - Frequently Asked Questions (FAQ)

What is the current Eli Lilly share price?
The current share price of Eli Lilly is US$ 912.76
How many Eli Lilly shares are in issue?
Eli Lilly has 948,169,999 shares in issue
What is the market cap of Eli Lilly?
The market capitalisation of Eli Lilly is USD 865.45B
What is the 1 year trading range for Eli Lilly share price?
Eli Lilly has traded in the range of US$ 711.4001 to US$ 972.53 during the past year
What is the PE ratio of Eli Lilly?
The price to earnings ratio of Eli Lilly is 81.72
What is the cash to sales ratio of Eli Lilly?
The cash to sales ratio of Eli Lilly is 19.21
What is the reporting currency for Eli Lilly?
Eli Lilly reports financial results in USD
What is the latest annual turnover for Eli Lilly?
The latest annual turnover of Eli Lilly is USD 45.04B
What is the latest annual profit for Eli Lilly?
The latest annual profit of Eli Lilly is USD 10.59B
What is the registered address of Eli Lilly?
The registered address for Eli Lilly is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204
What is the Eli Lilly website address?
The website address for Eli Lilly is www.lilly.com
Which industry sector does Eli Lilly operate in?
Eli Lilly operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
TACTransAlta Corporation
US$ 13.99
(49.15%)
2
ACAssociated Capital Group Inc
US$ 49.99
(37.00%)
1
GBTGGlobal Business Travel Group Inc
US$ 9.99
(25.19%)
11
XPROExpro Group Holdings NV
US$ 12.55
(22.80%)
11
EVCEntravision Communications Corp
US$ 2.48
(19.23%)
2
CPFCentral Pacific Financial Corp
US$ 11.29
(-58.89%)
2
HPEHewlett Packard Enterprise Co
US$ 14.32
(-20.27%)
92.47k
AKRAcadia Realty Trust
US$ 19.23
(-14.61%)
9
WLYBJohn Wiley and Sons Inc
US$ 32.01
(-14.30%)
1
BBAIBigBear ai Holdings Inc
US$ 3.62
(-13.81%)
191.32k
BBAIBigBear ai Holdings Inc
US$ 3.62
(-13.81%)
191.32k
BABAAlibaba Group Holding Limited
US$ 143.75
(2.72%)
113.92k
HPEHewlett Packard Enterprise Co
US$ 14.32
(-20.27%)
92.47k
XPEVXPeng Inc
US$ 23.30
(4.81%)
61.26k
OKLOOklo Inc
US$ 27.01
(4.00%)
58.43k

LLY Discussion

게시물 보기
BottomBounce BottomBounce 2 월 전
Eli Lilly and Company $LLY Total Debt (mrq) $31.23B Massive debt compared to dwinding cash. Pump and dump
👍️0
peanutz peanutz 2 월 전
Another gloom and doomer . Lilly is fine . I worked there over 10 years and they have a ton in the pipeline . It needs a breather . Crash my a$$
👍️0
MartinLutherKing MartinLutherKing 2 월 전
RNAZ micro rna cancer cure ELAB el-22 obesity target buyout in progress
👍️ 1
MomsSpaghetti MomsSpaghetti 2 월 전
Are you saying small biotech has a chance...? I was thinking the other way...

Eli Lilly has been a major player in CNS disorders, particularly with treatments for depression (e.g., Prozac) and schizophrenia. They are actively exploring new areas in psychiatry, including the potential for psychedelics.

Lilly has shown interest in novel treatments for depression and anxiety and has partnered with companies in the psychedelic space. Their expansion into the psychedelic field could be an opportunity to leverage MindMed's expertise in developing treatments using substances like LSD and MDMA.

I am wondering if they (or others) would might possibly acquire them.
👍️0
fung_derf fung_derf 3 월 전
I've been waiting and waiting for this one to pull back and it has. However, it is fighting mightily to hold support here....Right now I'm thinking it looks moderately hopeful here, but I think $NVO has become the better play now.
👍️0
Saving Grace Saving Grace 4 월 전
Industry changing direction. Big Pharma going south! LLY a major short candidate going into 2025.
👍️0
TechandBio TechandBio 5 월 전
$1000 strikes for Jan 2025 look juicy.

$LLY
👍️0
uksausage uksausage 5 월 전
why?
👍️0
Saving Grace Saving Grace 5 월 전
Big Pharma to crash hard. Be prepared!
👍️0
TechandBio TechandBio 5 월 전
Wonder if Lily Buys SMMT.
$LLY
👍️0
DewDiligence DewDiligence 6 월 전
LLY offers Zepbound in_single-use_vials_at_sharply_reduced_prices—(yesterday’s news):

https://www.nytimes.com/2024/08/27/well/eli-lilly-zepbound-price.html On Tuesday, Eli Lilly announced that it would start selling low doses of its weight-loss drug Zepbound in vials… — at a far lower price than its pens, which come with pre-filled doses. These vials will be made available only through LillyDirect, a telehealth platform the company launched in January (https://investor.lilly.com/news-releases/news-release-details/lilly-launches-end-end-digital-healthcare-experience-through ).

…The vials are significantly cheaper than Zepbound pens, which cost just over $1,000 a month without insurance. A month’s supply of the 2.5-milligram dose will cost $399, and a month’s worth of the five-milligram dose will cost $549.

… The company will offer vials with only the two lowest doses of Zepbound. Many patients stay on a five milligram dose… but some gradually increase their dose, up to a maximum of 15 milligrams. Any patient interested in taking more than the five-milligram dose would have to transition to the pens.

…the move could help Lilly regain customers who are currently getting compounded tirzepatide, which typically costs between roughly $250 and $450 a month. Why would anyone want a compounded formulation of tirzepatide derived from Chinese API when they can get the real thing from LLY at close to the same price?
👍️0
Monksdream Monksdream 6 월 전
LLY new 52=week high
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
To quote Areosmith ' I'm back in the saddle again' . 💰
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
In the green premarket again. 🍷
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
Bought back in at open today. 🍷
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
In regards to new a pharma product.
👍️0
Zardiw Zardiw 7 월 전
$LLY Chart from #DDAmanda - #1 Stock Screener :



Z
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
Just sold my LLY shares. Wonderful way to ease into the weekend. Good luck to everyone today.
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
Added @ $866.29
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
Going to be another green day.
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
I don't think they have sales in Europe yet, that'll change. 💰💰💰
👍️0
EnchantedTitan62 EnchantedTitan62 7 월 전
Uh, probably not .
👍️0
Monksdream Monksdream 8 월 전
LLY new 52=week high
👍️0
EL Sueno EL Sueno 8 월 전
Let's go fans 1000.00!!!
👍️0
Monksdream Monksdream 8 월 전
LLY new 52 week high
👍️0
Monksdream Monksdream 9 월 전
LLY new 52 week high
👍️0
Monksdream Monksdream 10 월 전
LLY 10Q due 4/30
Next day setttlement begins 5/28
👍️0
north40000 north40000 12 월 전
FDA advises LLY it wants AdCom meeting. Portends delay. Meanwhile NVO CEO was interviewed on CNBC-TV this morning, repeats NVO’s PR warning dated in January 2024 that it will not have manufacturing capacity to fill demand for its weight loss drug until 2006(?).
👍️0
Alfonz66 Alfonz66 12 월 전
Sell now boys you had a great run
👍️0
Monksdream Monksdream 1 년 전
LLY new 52 week high
👍️0
Monksdream Monksdream 1 년 전
LLY new 52 week high

👍️0
oldstocks oldstocks 1 년 전
Eli Lilly was investigating Talampanel prior to 2010

For the treatment of epilepsy, malignant gliomas and ALS
development codes LY-300164 , LY300164
results from the trial for ALS have been found negative
Talampanel is not currently under development.
It showed effectiveness for epilepsy in clinical trials but its development was suspended due to its poor pharmacokinetic profile, namely a short terminal half-life (3 hours) that necessitated multiple doses per day.
RespireRx Pharmaceuticals $ RSPI a little unknown company KRM–II–81 has shown promising results for Epilepsy.
Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
👍️0
ralphey ralphey 1 년 전
I bought Lilly about a year ago based on Mounjaro and knowing it was going to be a success. I am a FAmily Doc who has done bariatric medicine for 30 years. Zepbound definitely is inducing more weight loss than Ozempic (Wegovy) but I am getting concerned over the number of patients that are stopping zepbound / Mounjaro due to side effects, seems a lot more than on Ozempic ( Wegovy) .
👍️0
Monksdream Monksdream 1 년 전
Incredible, isn’t it
What gets me about these social media bozos is they actually believe they will become Boca Raton rich by day trading sub $1 stocks
Because they are incapable of researching companies
🌈 1 🍆 1
vinsterr vinsterr 1 년 전
800$ tomorrow?
👍️0
Monksdream Monksdream 1 년 전
LLY new 52=week high
👍️0
Monksdream Monksdream 1 년 전
LLY new 52 week high
👍️0
Monksdream Monksdream 1 년 전
LLY new 52 week high
👍️0
Monksdream Monksdream 1 년 전
LLY new 52 week high
🍆 1
lvhd lvhd 1 년 전
Shorted at 625.
👍️0
golfndude golfndude 1 년 전
Great news on their new diabetes drug.
👍️0
peanutz peanutz 1 년 전
Looking for the bottom ,not yet :)
👍️0
Monksdream Monksdream 1 년 전
LLY new 52 week high
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 년 전
Amazing financials
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 년 전
Billionaires dream a while back, speculating
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 년 전
Interesting company
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 년 전
Wowwwwwww
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 년 전
Knew this company from the 80 ssssss
👍️0
Monksdream Monksdream 1 년 전
LLY new 52 week high
👍️0
lvhd lvhd 1 년 전
Who is pumping?
👍️0

최근 히스토리

NYSE
LLY
Eli Lilly
LSE
36ZI
Nat Gas Micro
LSE
86HK
Euro.bk.33
LSE
PL66
Haleon Uk 28
LSE
FF25
Cad. Fin.30
LSE
JV48
Morocco 33a
LSE
35CV
Euro.bk. 39
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지